[{"id":"ahn-myung-ju","kind":"person","name":"Myung-Ju Ahn","route":"/people/ahn-myung-ju/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/people/asia-pacific.ts","type":"changed","fields":[{"field":"tldr","before":"\"One of Asia's most prolific lung cancer trialists, a steady presence on the steering committees of the EGFR, ALK, and immunotherapy trials that set today's standards.\"","after":"\"Myung-Ju Ahn is one of Asia's most prolific lung cancer trialists, a steady presence on the steering committees of the EGFR, ALK, and immunotherapy trials that set today's standards.\""}]},{"id":"ahn-myung-ju","kind":"person","name":"Myung-Ju Ahn","route":"/people/ahn-myung-ju/","commit":"9b4eb0eb88","date":"2026-09-08","author":"Jude Gomila","message":"Add Asia-Pacific, Canada, Brazil, and IARC/WHO people (91 person entities)","file":"src/data/people/asia-pacific.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"role"},{"field":"institutionId"},{"field":"institutions"},{"field":"specialisms"},{"field":"tldr"},{"field":"summary"},{"field":"profiles"},{"field":"papers"},{"field":"cancers"},{"field":"targets"},{"field":"drugs"},{"field":"trials"},{"field":"tags"}]}]